Question 1

What is combined oxidative phosphorylation deficiency 28?

Accepted Answer

Combined oxidative phosphorylation deficiency 28 is a condition that disrupts the body’s ability to produce energy efficiently due to impaired mitochondrial function. The disorder is caused by mutations in the SLC25A26 gene, which plays a critical role in mitochondrial transport processes. Affected individuals are typically identified early, often during the neonatal period when metabolic challenges appear. This condition is very rare, affecting fewer than 1 in 1,000,000 people.

Question 2

What are the symptoms of combined oxidative phosphorylation deficiency 28?

Accepted Answer

Clinical features associated with combined oxidative phosphorylation deficiency 28 include an increased circulating pyruvate concentration and generalized hypotonia, noted in a subset of affected individuals. These findings represent some of the more frequently observed abnormalities; however, not all individuals experience every symptom and severity varies considerably. Although not all characteristic findings have been delineated, the presence of these biochemical and neuromuscular features often prompts further evaluation.

Question 3

What causes combined oxidative phosphorylation deficiency 28?

Accepted Answer

This condition is caused by mutations in the SLC25A26 gene, which encodes a protein essential for the transport of molecules necessary for proper mitochondrial function. It is inherited in an autosomal recessive pattern, meaning that an affected individual must receive a mutated copy of the gene from each parent. This condition is more common when parents share a common ancestor, as the likelihood of both carrying the same rare genetic variant increases. Genetic counseling is recommended to help families understand the inheritance pattern and discuss family planning options. Associated genes include SLC25A26.

Question 4

How is combined oxidative phosphorylation deficiency 28 inherited?

Accepted Answer

combined oxidative phosphorylation deficiency 28 follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How rare is combined oxidative phosphorylation deficiency 28?

Accepted Answer

combined oxidative phosphorylation deficiency 28 is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is combined oxidative phosphorylation deficiency 28 diagnosed?

Accepted Answer

The definitive diagnosis of combined oxidative phosphorylation deficiency 28 is made through molecular genetic testing that identifies pathogenic variants in the SLC25A26 gene. Clinical evaluation, including a review of medical history, examination of symptoms such as hypotonia, and laboratory findings like an increased circulating pyruvate concentration, also contribute to the diagnostic process. Because these features can overlap with other metabolic disorders, genetic testing is essential to confirm the diagnosis.

Question 7

Are there treatments for combined oxidative phosphorylation deficiency 28?

Accepted Answer

Currently, management of combined oxidative phosphorylation deficiency 28 focuses on supportive care and symptom management because there are no specific approved treatments for this condition. Treatment is tailored to each individual and typically involves a multidisciplinary team that may include metabolic specialists, physical therapists, and nutrition experts. Patients should discuss treatment options with their healthcare team to determine which supportive interventions may be most appropriate, and genetic counseling is recommended to assist with family planning and further guidance.

Question 8

What complications can arise from combined oxidative phosphorylation deficiency 28?

Accepted Answer

Complications from combined oxidative phosphorylation deficiency 28 can vary widely among individuals. Some may experience significant challenges related to muscle weakness, while others might face metabolic issues due to the impaired energy production. Regular monitoring by healthcare providers is important to manage any complications that may arise.

Question 9

How does combined oxidative phosphorylation deficiency 28 affect daily life for patients?

Accepted Answer

Daily life for patients with combined oxidative phosphorylation deficiency 28 can be impacted by symptoms like generalized hypotonia and fatigue. Supportive care, including physical therapy and nutritional guidance, can help improve quality of life. Families often work closely with a healthcare team to create a routine that accommodates the patient's needs.

Question 10

What is the prognosis for someone with combined oxidative phosphorylation deficiency 28?

Accepted Answer

The prognosis for individuals with combined oxidative phosphorylation deficiency 28 varies based on symptom severity and age at diagnosis. Some may experience a stable condition with proper management, while others may face ongoing challenges. Supportive care can improve quality of life, and families are encouraged to stay informed about evolving treatment options.

Question 11

Should families consider genetic counseling when dealing with combined oxidative phosphorylation deficiency 28?

Accepted Answer

Yes, families should consider genetic counseling when dealing with combined oxidative phosphorylation deficiency 28. Genetic counseling can help families understand the inheritance pattern of the condition and discuss family planning options. It provides valuable information for parents who may be carriers of the SLC25A26 gene mutation.

Organ System	Phenotype Count	Example Features
Lab test results	4	Increased circulating pyruvate concentration, Increased circulating lactate concentration, Decreased activity of mitochondrial complex I
Muscles	3	Ragged-red muscle fibers, Generalized hypotonia, Muscle weakness
Brain and nerves	2	Global developmental delay, Fatigue
Pregnancy and birth	1	Decreased fetal movement
Heart and blood vessels	1	Congestive heart failure
Lungs and breathing	1	Respiratory failure
Digestive system	1	Abdominal pain

Kisho

combined oxidative phosphorylation deficiency 28

Overview

Clinical Presentation

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

combined oxidative phosphorylation deficiency 28

Overview

Clinical Presentation

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is combined oxidative phosphorylation deficiency 28?

What are the symptoms of combined oxidative phosphorylation deficiency 28?

What causes combined oxidative phosphorylation deficiency 28?

How is combined oxidative phosphorylation deficiency 28 inherited?

How rare is combined oxidative phosphorylation deficiency 28?

How is combined oxidative phosphorylation deficiency 28 diagnosed?

Are there treatments for combined oxidative phosphorylation deficiency 28?

What complications can arise from combined oxidative phosphorylation deficiency 28?

How does combined oxidative phosphorylation deficiency 28 affect daily life for patients?

What is the prognosis for someone with combined oxidative phosphorylation deficiency 28?

Should families consider genetic counseling when dealing with combined oxidative phosphorylation deficiency 28?

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications